Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IP
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | William Thomas Hamic Exec. VP & President | IP International Paper Company | Sale | 24,500 | $41.20 | $1.0M Sale | Form 4 ↗ |
| Aug 4, 2026 | Holly G. Goughnour VP & Chief Accounting Officer | IP International Paper Company | Sale | 3,500 | $41.96 | $146.9K Sale | Form 4 ↗ |
| May 1, 2026 | Scott Tozier Director | IP International Paper Company | Buy | 10,000 | $31.30 | $313.0K Buy | Form 4 ↗ |
| Mar 12, 2026 | Anders Gustafsson Director | IP International Paper Company | Buy | 13,217 | $37.83 | $500.0K Buy | Form 4 ↗ |
| Mar 11, 2026 | Anders Gustafsson Director | IP International Paper Company | Buy | 12,875 | $38.84 | $500.1K Buy | Form 4 ↗ |
| Jan 30, 2026 | Christopher M. Connor Director | IP International Paper Company | Buy | 25,000 | $40.37 | $1.0M Buy | Form 4 ↗ |
| Jan 30, 2026 | Andrew K. Silvernail Chief Executive Officer | IP International Paper Company | Buy | 50,000 | $39.98 | $2.0M Buy | Form 4 ↗ |
| Nov 18, 2025 | Clay R. Ellis Senior Vice President | IP International Paper Company | Sale | 18,819 | $36.85 | $693.5K Sale | Form 4 ↗ |
| Sep 16, 2025 | Joseph R. Saab SVP, GC and Corp. Secretary | IP International Paper Company | Sale | 9,000 | $45.54 | $409.9K Sale | Form 4 ↗ |
| May 5, 2025 | Holly G. Goughnour VP & Chief Accounting Officer | IP International Paper Company | Sale | 7,500 | $44.85 | $336.4K Sale | Form 4 ↗ |
| Nov 29, 2024 | Kathryn D. Sullivan Director | IP International Paper Company | Sale | 600 | $58.39 | $35.0K Sale | Form 4 ↗ |
| Nov 15, 2024 | Kathryn D. Sullivan Director | IP International Paper Company | Sale | 600 | $56.19 | $33.7K Sale | Form 4 ↗ |
| Oct 31, 2024 | Kathryn D. Sullivan Director | IP International Paper Company | Sale | 600 | $53.50 | $32.1K Sale | Form 4 ↗ |
| Oct 15, 2024 | Kathryn D. Sullivan Director | IP International Paper Company | Sale | 600 | $48.08 | $28.8K Sale | Form 4 ↗ |
| Sep 30, 2024 | Kathryn D. Sullivan Director | IP International Paper Company | Sale | 600 | $48.68 | $29.2K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances